Impact of meditation on Telomere length of cancer patients on chemotherapy

INTERVENTION: Intervention1: Heartfulness CARE support program: Heartfulness meditation intervention includes 15‐minute morning relaxation with visualization and 15‐minute evening rejuvenation practices, supported by weekly trainer‐led sessions. Participants use guided resources and maintain diaries to track symptoms and adherence over time. Control Intervention1: Standard medical care: Participants in the control arm receive standard medical care, including routine clinical treatment, regular follow‐ups, and supportive care as prescribed by healthcare providers, without exposure to meditation or Heartfulness‐based interventions during the study period. CONDITION: Health Condition 1: C509‐ Malignant neoplasm of breast of unspecified site PRIMARY OUTCOME: To estimate the impact of meditation on the telomere length of cancer patients on chemotherapy.Timepoint: one year SECONDARY OUTCOME: To measure the effect of meditation on psychological wellbeing among study participants by perceived stress level questionnaire. ; ; Timepoint: one year INCLUSION CRITERIA: Female patients of breast cancer, 3 to 6 months of post diagnosis and on chemotherapy with performance status of 0, 1, 2 of Eastern Cooperative Oncology Group (ECOG)/WHO system